According to Augmedix's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.1. At the end of 2024 the company had a P/S ratio of 0.8354.
Year | P/S ratio | Change |
---|---|---|
2024 | 0.8354 | -86.81% |
2023 | 6.33 | 235.45% |
2022 | 1.89 | -64.25% |
2021 | 5.28 |